Skip to main content
logo
TTY Biopharm Company Limited (TPEX:4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
73.50
-0.20 (-0.27%)
Jun 18, 2026, 1:30 PM CST

Revenue by Segment

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Export and OEM Business Unit
1.25B1.02B796.70M653.68M-
Export and OEM Business Unit Growth
22.00%28.55%21.88%--
Healthcare Unit
263.43M262.41M195.63M581.66M221.48M
Healthcare Unit Growth
0.39%34.14%-66.37%162.62%4.16%
Re-investment Business Unit
1.43B1.24B814.45M747.28M-
Re-investment Business Unit Growth
15.55%51.71%8.99%--
Intensive Care Business Unit
1.50B1.32B1.20B899.62M1.14B
Intensive Care Business Unit Growth
13.80%9.41%33.77%-20.80%14.79%
Adjustments and Eliminations
-512.98M-444.41M--268.62M-274.72M
Oncology Business Unit
2.50B2.46B2.43B2.34B2.77B
Oncology Business Unit Growth
1.65%1.41%3.78%-15.44%6.18%
Other Business Unit
21.92M35.23M65.44M106.64M270.72M
Other Business Unit Growth
-37.78%-46.16%-38.64%-60.61%38.09%
Cardiovascular and Gastrointestinal Drugs Business Group
----413.48M
Cardiovascular and Gastrointestinal Drugs Business Group Growth
-----7.68%
Total
6.45B5.89B5.51B5.06B4.54B
Total Growth
9.49%7.05%8.77%11.60%7.43%

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Taiwan
5.49B5.12B4.84B4.60B4.25B
Taiwan Growth
7.22%5.78%5.24%8.33%8.01%
America
557.54M381.29M265.71M59.43M-
America Growth
46.22%43.50%347.07%--
Other Countries
405.11M391.78M398.66M402.12M289.25M
Other Countries Growth
3.40%-1.73%-0.86%39.02%4.04%
Total
6.45B5.89B5.51B5.06B4.54B
Total Growth
9.49%7.05%8.77%11.60%7.43%